Concepedia

Author

Marinos Tsiatas

National and Kapodistrian University of AthensORCID

Also Known As

M L Tsiatas, M TSIATAS, M Tsiatas, M. Tsiatas, M.L. Tsiatas, Mangesh Thorat, Marinos L Tsiatas, Marinos L. Tsiatas, Marinos L. Tsiatas, MD, PhD, Marinos Tsiatas

65

Publications

2.4K

Citations

22

H-Index

54

Concepts

All Affiliations

National and Kapodistrian University of AthensAlexandra HospitalAthens Medical CenterLaiko General Hospital of AthensSt Savas Hospital
MT

About

Marinos Tsiatas is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

1.8K

2

Cell Biology

3

3

203

3

Natural Sciences

1

1

28

4

Public Health

1

1

21

5

Biochemistry

1

1

28

Marinos Tsiatas

×

26

Publications

1.7K

Citations

19

H-Index

YearCitations

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Thomas Powles, Michiel S. van der Heijden, Daniel Castellano,

The Lancet Oncology

2020

485

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2

Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas,

International Journal of Cancer

2011

162

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis,

British Journal of Cancer

2012

161

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Aristotelis Bamias, Urania Dafni, Alexandra Karadimou,

Annals of Oncology

2012

97

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy

Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos,

Gynecologic Oncology

2007

92

Compromised anti-tumor responses in tumor necrosis factor-α knockout mice

Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis,

European Journal of Immunology

2000

79

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance

Aristotelis Bamias, Marinos Tsiatas, Eftychia Kafantari,

Gynecologic Oncology

2007

76

Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: The impact of inflammatory process and oxidative stress

Dimitris Tousoulis, Ioannis Andreou, Marinos Tsiatas,

Atherosclerosis

2010

68

Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

Ioannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas,

Journal of Translational Medicine

2011

53

Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?

Flora Zagouri, George Bozas, Eftichia Kafantari,

Obstetrics and Gynecology International

2010

48

Page 1